PortfoliosLab logoPortfoliosLab logo
NMR vs. UBS
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

NMR vs. UBS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nomura Holdings, Inc. (NMR) and UBS Group AG (UBS). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NMR vs. UBS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NMR
Nomura Holdings, Inc.
-2.86%54.10%34.05%21.84%-10.28%-18.76%4.39%38.71%-36.08%0.16%
UBS
UBS Group AG
-14.19%60.21%2.03%67.65%5.92%27.93%17.99%7.15%-32.68%21.53%

Fundamentals

Market Cap

NMR:

$24.72B

UBS:

$131.40B

EPS

NMR:

$118.00

UBS:

$2.27

PE Ratio

NMR:

0.07

UBS:

17.48

PEG Ratio

NMR:

0.00

UBS:

0.32

PS Ratio

NMR:

0.01

UBS:

2.02

PB Ratio

NMR:

0.01

UBS:

1.46

Total Revenue (TTM)

NMR:

$4.38T

UBS:

$65.02B

Gross Profit (TTM)

NMR:

$1.80T

UBS:

$46.85B

EBITDA (TTM)

NMR:

$529.89B

UBS:

$12.04B

Returns By Period

In the year-to-date period, NMR achieves a -2.86% return, which is significantly higher than UBS's -14.19% return. Over the past 10 years, NMR has underperformed UBS with an annualized return of 8.80%, while UBS has yielded a comparatively higher 13.19% annualized return.


NMR

1D
3.30%
1M
-5.78%
YTD
-2.86%
6M
14.15%
1Y
36.80%
3Y*
34.12%
5Y*
12.12%
10Y*
8.80%

UBS

1D
1.71%
1M
-2.79%
YTD
-14.19%
6M
-1.68%
1Y
37.34%
3Y*
27.18%
5Y*
23.22%
10Y*
13.19%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NMR vs. UBS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NMR
NMR Risk / Return Rank: 7272
Overall Rank
NMR Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
NMR Sortino Ratio Rank: 6868
Sortino Ratio Rank
NMR Omega Ratio Rank: 7070
Omega Ratio Rank
NMR Calmar Ratio Rank: 7171
Calmar Ratio Rank
NMR Martin Ratio Rank: 7676
Martin Ratio Rank

UBS
UBS Risk / Return Rank: 7373
Overall Rank
UBS Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
UBS Sortino Ratio Rank: 7575
Sortino Ratio Rank
UBS Omega Ratio Rank: 7272
Omega Ratio Rank
UBS Calmar Ratio Rank: 6868
Calmar Ratio Rank
UBS Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NMR vs. UBS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nomura Holdings, Inc. (NMR) and UBS Group AG (UBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NMRUBSDifference

Sharpe ratio

Return per unit of total volatility

1.10

1.29

-0.18

Sortino ratio

Return per unit of downside risk

1.57

1.87

-0.30

Omega ratio

Gain probability vs. loss probability

1.22

1.24

-0.02

Calmar ratio

Return relative to maximum drawdown

1.59

1.38

+0.21

Martin ratio

Return relative to average drawdown

4.90

4.01

+0.89

NMR vs. UBS - Sharpe Ratio Comparison

The current NMR Sharpe Ratio is 1.10, which is comparable to the UBS Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of NMR and UBS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


NMRUBSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.10

1.29

-0.18

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.41

0.77

-0.36

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.28

0.43

-0.15

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.01

0.34

-0.35

Correlation

The correlation between NMR and UBS is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

NMR vs. UBS - Dividend Comparison

NMR's dividend yield for the trailing twelve months is around 2.13%, less than UBS's 3.41% yield.


TTM20252024202320222021202020192018201720162015
NMR
Nomura Holdings, Inc.
2.13%4.91%4.29%1.20%3.86%0.00%0.86%0.00%0.00%1.70%1.79%3.34%
UBS
UBS Group AG
3.41%2.92%3.46%0.89%1.34%1.04%3.87%5.48%0.00%3.30%5.42%3.87%

Drawdowns

NMR vs. UBS - Drawdown Comparison

The maximum NMR drawdown since its inception was -89.27%, which is greater than UBS's maximum drawdown of -61.38%. Use the drawdown chart below to compare losses from any high point for NMR and UBS.


Loading graphics...

Drawdown Indicators


NMRUBSDifference

Max Drawdown

Largest peak-to-trough decline

-89.27%

-61.38%

-27.89%

Max Drawdown (1Y)

Largest decline over 1 year

-22.43%

-26.07%

+3.64%

Max Drawdown (5Y)

Largest decline over 5 years

-44.70%

-33.41%

-11.29%

Max Drawdown (10Y)

Largest decline over 10 years

-55.34%

-61.38%

+6.04%

Current Drawdown

Current decline from peak

-59.96%

-19.31%

-40.65%

Average Drawdown

Average peak-to-trough decline

-61.52%

-19.41%

-42.11%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.28%

8.99%

-1.71%

Volatility

NMR vs. UBS - Volatility Comparison

Nomura Holdings, Inc. (NMR) and UBS Group AG (UBS) have volatilities of 10.64% and 10.28%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


NMRUBSDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.64%

10.28%

+0.36%

Volatility (6M)

Calculated over the trailing 6-month period

22.42%

19.48%

+2.94%

Volatility (1Y)

Calculated over the trailing 1-year period

33.49%

29.16%

+4.33%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

29.35%

30.15%

-0.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.01%

30.42%

+0.59%

Financials

NMR vs. UBS - Financials Comparison

This section allows you to compare key financial metrics between Nomura Holdings, Inc. and UBS Group AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00B400.00B600.00B800.00B1.00T1.20TAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
1.17T
9.50B
(NMR) Total Revenue
(UBS) Total Revenue
Values in USD except per share items